Glycogen storage disease is a generic term that describes a group of inherited disorders characterized by deposition of an abnormal type or quantity of glycogen in the tissues.
Red blood cells and the brain have an absolute requirement for blood glucose for their energy metabolism, consuming about 80% of the glucose consumed per day by a 70 kg human, in good health.
Pyrophosphate (PPi), is hydrolyzed to two inorganic phosphates (Pi) by pyrophosphatase, ensuring that the UDP-glucose pyrophosphorylase reaction proceeds in the direction of UDP-glucose production.
Luis Leloir and his coworkers showed that glycogen is synthesized by a pathway that utilizes uridine diphosphate glucose (UDP-glucose) rather than glucose 1-phosphate as the activated glucose donor.
Once glucose 1-Phosphate is formed, it needs to be activated by adding another phosphoryl group and a uridine molecule to form uridine diphosphate (UDP) - glucose.
Unlike hepatocytes, myocytes have a reserve of GLUT4 sequestered in intracellular vesicles, and insulin triggers their movement to the plasma membrane, where they allow increased glucose uptake.